ModelEdge

Scinai Immunotherapeutics Ltd
SCNI
Filing Type20-F
Filing Date5/12/2021
Updated5/13/21, 11:19 AM

Filing

20-F
Earnings Release

Exhibits

20-FAnnual and Transition Report of Foreign Private Issuers
EX-1.1ARTICLES OF ASSOCIATION OF BIONDVAX PHARMACEUTICALS LTD
EX-2.3DESCRIPTION OF SHARE CAPITAL
EX-4.3REMUNERATION POLICY
EX-4.16AMENDMENT NO. 1 DATED JANUARY 11, 2021 TO FINANCE CONTRACT DATED JUNE 19, 2017, BY AND BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND THE EUROPEAN INVESTMENT BANK
EX-12.1CERTIFICATION
EX-12.2CERTIFICATION
EX-13.1CERTIFICATION
EX-13.2CERTIFICATION
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
EX-101.INSXBRL INSTANCE FILE